In studies investigating the influence of sevoflurane on Smad3 signalling, which regulates cell proliferation, differentiation and cell death, proliferation is increased in non-small cell lung carcinomas (NSCLC) whereas in contrast it is decreased in renal cell carcinoma, therefore, producing contrary effects. This evidence concerns the gene SMAD3 and non-small cell lung carcinoma.